These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3445176)

  • 1. [Clinical evaluation of the antitumor effectiveness of spirobromine].
    Borisov VI; Chernov VA; Dement'eva NP; Korobkova LI; Bogdanova NV
    Sov Med; 1987; (12):42-3. PubMed ID: 3445176
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
    Brenner DE; Jones HW; Rosenshein NB; Forastiere A; Dillon M; Grumbine F; Tipping S; Burnett L; Greco FA; Wiernik PH
    Cancer Treat Rep; 1983 Feb; 67(2):193-4. PubMed ID: 6825131
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of spirogermanium for treatment of advanced breast cancer.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1983 Feb; 67(2):189-90. PubMed ID: 6825129
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of spirogermanium in the treatment of metastatic breast cancer.
    Pinnamaneni K; Yap HY; Legha SS; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1984 Sep; 68(9):1197-8. PubMed ID: 6478457
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.
    Kavanagh JJ; Saul PB; Copeland LJ; Gershenson DM; Krakoff IH
    Cancer Treat Rep; 1985 Jan; 69(1):139-40. PubMed ID: 3967257
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
    Budman DR; Ginsberg S; Perry M; Weinberg V; Schein P; Hanson J; Coleman M; Wood W
    Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.
    Weiselberg L; Budman DR; Schulman P; Vinciguerra V; Degnan TJ; Pasmantier M
    Cancer Treat Rep; 1982 Aug; 66(8):1675-6. PubMed ID: 7201885
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.
    Schulman P; Davis RB; Rafla S; Green M; Henderson E
    Cancer Treat Rep; 1984 Oct; 68(10):1305-6. PubMed ID: 6525606
    [No Abstract]   [Full Text] [Related]  

  • 9. Atiprimod: a multi-functional drug candidate for myeloid and other malignancies.
    Shailubhai K
    Leuk Res; 2007 Jan; 31(1):9-10. PubMed ID: 16860863
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I clinical trial of spirogermanium.
    Schein PS; Slavik M; Smythe T; Hoth D; Smith F; Macdonald JS; Woolley PV
    Cancer Treat Rep; 1980; 64(10-11):1051-6. PubMed ID: 7459890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
    Dhingra HM; Umsawasdi T; Chiuten DF; Murphy WK; Holoye PY; Spitzer G; Valdivieso M
    Cancer Treat Rep; 1986 May; 70(5):673-4. PubMed ID: 3708617
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effectiveness of experimental combined chemical and radiotherapy].
    Zedgenidze GA; Amosov IS; Kaperko FF; Kharlampovich SI; Podsosov SP; Tylechkina OD
    Med Radiol (Mosk); 1967 Apr; 12(4):3-8. PubMed ID: 6052181
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.
    Boros L; Tsiatis AA; Neiman RS; Mann RB; Glick JH
    Cancer Treat Rep; 1986 Jul; 70(7):917-8. PubMed ID: 3719586
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effectiveness of treating dermal reticulosis with prospidin and fotrin].
    Mukhamedov N
    Vestn Dermatol Venerol; 1973 Jan; 47(1):49-52. PubMed ID: 4575610
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs].
    Wang ZY
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of chemotherapy with platinum compounds.
    Walker EM; Walker SM
    Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of spirogermanium in advanced ovarian malignancy.
    Tropé C; Mattsson W; Gynning I; Johnsson JE; Sigurdsson K; Orbert B
    Cancer Treat Rep; 1981; 65(1-2):119-20. PubMed ID: 6261944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of spirogermanium in advanced breast cancer.
    Kuebler JP; Tormey DC; Harper GR; Chang YC; Khandekar JD; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1515-6. PubMed ID: 6509457
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
    Bui NB; Chauvergne J; Brunet R; Richaud P; Hoerni B; Lagarde C; Le Guillou M
    Bull Cancer; 1986; 73(1):65-7. PubMed ID: 3779124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.